News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Advts:
Classifieds |
Employment |
Business
-
Briefly
Matrix Lab unit gets USFDA nod
HYDERABAD:
Matrix Laboratories has received U.S. FDA approval for its Active Pharmaceutical Ingredients (APIs) manufacturing facility located at Kazipally (unit II) near Hyderabad. The facility now manufactures anti-retrovirals for the treatment of HIV/AIDS. The approval will enable the company to supply ARV APIs to the President Bush's PEPFAR (The President's Emergency Plan for AIDS Relief), programme besides other regulated markets, says a release. The company said it had filed 46 Drug Master files (DMFs) with U.S. FDA as of March.
Printer friendly
page
Send this article to Friends by
E-Mail
Business
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Advts:
Classifieds |
Employment |
Updates:
Breaking News |
|
